Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-19-009744

CEO sold 5,193 shares at $25.83 ($134,135)

  • CEO acquired 8,283 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Collins Cynthia · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-08-19 Grant or award : show line 1 in the form +8,283 16,566 D
2019-08-19 Sale : show line 2 in the form −5,193 $25.83 $134,135 11,373 D
Open-market sales · 5,193 sh · avg $25.83 · $134,135
Loading xslF345X03/edgar.xml…